{"id":564,"date":"2010-04-01T12:03:00","date_gmt":"2010-04-01T10:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2010\/richtlinien-fuer-die-behandlung-der-polymyalgia-rheumatica"},"modified":"2010-04-01T12:03:00","modified_gmt":"2010-04-01T10:03:00","slug":"richtlinien-fuer-die-behandlung-der-polymyalgia-rheumatica","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2010\/richtlinien-fuer-die-behandlung-der-polymyalgia-rheumatica","title":{"rendered":"Richtlinien f\u00fcr die Behandlung der Polymyalgia rheumatica"},"content":{"rendered":"<p>Die British Society for Rheumatology hat zusammen mit den British Health Professionals in Rheumatology k\u00fcrzlich auf Expertenmeinungen basierende Richtlinien f\u00fcr die Behandlung der Polymyalgia rheumatica (PMR), der h\u00e4ufigsten rheumatologischen Erkrankung \u00e4lterer Menschen, ver\u00f6ffentlicht (1). Wir referieren diese Richtlinien, weil wir den Eindruck haben, dass viele \u00c4rzte in Deutschland, gemessen an diesen Richtlinien, h\u00f6here Kortikosteroid-Dosen f\u00fcr [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Die British Society for Rheumatology hat zusammen mit den British Health Professionals in Rheumatology k\u00fcrzlich auf Expertenmeinungen basierende Richtlinien f\u00fcr die Behandlung der Polymyalgia rheumatica (PMR), der h\u00e4ufigsten rheumatologischen Erkrankung \u00e4lterer Menschen, ver\u00f6ffentlicht (1). Wir referieren diese Richtlinien, weil wir den Eindruck haben, dass viele \u00c4rzte in Deutschland, gemessen an diesen Richtlinien, h\u00f6here Kortikosteroid-Dosen f\u00fcr [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1212,1211,246,247,244,1214,1213,241,1210,1209],"class_list":["post-564","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-arteriitis-cranialis","tag-arteriitis-temporalis","tag-glukokortikoide","tag-glukokortikosteroide","tag-kortikosteroide","tag-m-horton","tag-polymyalgia-rheumatica","tag-prednisolon","tag-riesenzell-arteriitis","tag-riesenzellarteriitis"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=564"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/564\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}